Sulfonylureas for Type 2 Diabetes - Medication used to control type 2 diabetes
Links shared publicly online about this topic.
- 1,675total visits
Sulfonylureas for Type 2 Diabetes - Medication used to control type 2 diabetes
View full resource at endocrineweb.com
Tags: Diabetes, Type 2 Diabetes, Drug
Most Recently Shared on October 15, 2009 at 3:07 pm By:
Do you know the first medication developed to treat diabetes? Get the answer and learn more about it here: http://bit.ly/2eErIj
European Commission grants marketing authorization for use of BYETTA with basal insulin
news-medical.net — “Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the European Commission has granted marketing authorization to BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.” View full resource at news-medical.net
Most Recently Shared on March 23, 2012 at 1:57 pm By:
European Commission grants marketing authorization for use of BYETTA with basal insulin: Amylin Pharmaceuticals,... http://t.co/3EqmxLdM
Improved Diabetes Control and Pancreatic Function in a Type 2 Diabetic after Omeprazole Administration
hindawi.com — “A 43-year-old man with type 2 diabetes, opposed to insulin use and poorly responsive to oral agents added sequentially over 6 years, was placed on 40?mg omeprazole twice daily. A linear decline in daily fasting blood glucose was observed over the first two-month treatment, and his hemoglobin A1c was reduced from 11.9% to 8.2%, then sustained at 8.1% after four months. Glucose, insulin, and C-peptide response to a 2-hour glucose tolerance test were consistently improved across this time period, a” View full resource at hindawi.com
Most Recently Shared on March 14, 2012 at 9:55 pm By:
Urology & Nephrology OW Health
Improved Diabetes Control and Pancreatic Function in a Type 2 Diabetic after Omeprazole Administration: A 43-yea... http://t.co/pCUUt4VP
Researchers identify optimal threshold for HbA1c test for prediabetes
eurekalert.org — “Setting a specific HbA1c cutoff threshold for prediabetes, which could be used to determine eligibility for interventions to prevent progression to more serious type 2 diabetes, has generated much debate, with at least three different cutoffs recommended by different professional organizations. A new study led by the Centers for Disease Control and Prevention demonstrates that lowering the cutoff increases the health benefits of preventive interventions, although at higher cost. It concludes tha” View full resource at eurekalert.org
Most Recently Shared on March 13, 2012 at 5:39 am By:
Researchers identify optimal threshold for HbA1c test for prediabetes: ( Elsevier Health Sciences ) Setting a sp... http://t.co/OWBMhXko
Early glucose control halves kidney disease in type 1 diabetes - News
virtualmedicalcentre.com — “Controlling blood glucose early in the course of type 1 diabetes yields huge dividends, preserving kidney function for decades.” View full resource at virtualmedicalcentre.com
Most Recently Shared on December 4, 2011 at 1:10 pm By:
VirtualMedicalCentre Health Site
Early glucose control halves kidney disease in type 1 diabetes http://t.co/2useXBwX #Healthnews
European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes
news-medical.net — “Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved ONGLYZA (saxagliptin) for use as a combination therapy with insulin (with or without metformin) to improve blood sugar (glycaemic) control in adult patients with type 2 diabetes.” View full resource at news-medical.net
Most Recently Shared on November 28, 2011 at 5:30 pm By:
European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes: Bristol-Myers Squi... http://t.co/mO9KYHaO
European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes
news-medical.net — “Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved ONGLYZA (saxagliptin) for use as a combination therapy with insulin (with or without metformin) to improve blood sugar (glycaemic) control in adult patients with type 2 diabetes.” View full resource at news-medical.net
Most Recently Shared on November 28, 2011 at 3:53 pm By:
Diabetes News: European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes: Bri... http://t.co/IjDwRuPp
Garlic improves metformin therapy in type 2 diabetics. | GreenMedInfo | Article | Natural Medicine | Alternative Medicine | Integrative Medicine
greenmedinfo.com — “This article on GreenMedInfo.com concerns - Garlic (Allium sativum) supplementation with standard antidiabetic agent provides better diabetic control in type 2 diabetes patients.” View full resource at greenmedinfo.com
Most Recently Shared on October 10, 2011 at 12:07 pm By:
Blood sugar self-monitoring improves control in type 2 diabetes - Related Stories - ANA SmartBrief
smartbrief.com — “Patients who self-monitored their blood glucose had mean HbA1c levels of only 7.7% compared with 8.0% in a control group despite using fewer glucose test strips, a Structured Testing Program study found. The study looked at people with type 2 diabetes who did not take insulin. The study group was a…” View full resource at smartbrief.com
Most Recently Shared on August 20, 2011 at 9:52 pm By:
Blood sugar self-monitoring improves control in type 2 diabetes http://t.co/wF8ky8z
Downregulation of the Proinflammatory State of Circulating Mononuclear Cells by Short-Term Treatment with Pioglitazone in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease
hindawi.com — “Background. This study was performed to investigate the influence of a short-term treatment with pioglitazone versus placebo on inflammatory activation of mononuclear cells (mRNA expression/protein secretion of inflammatory markers). Methods and Results. Sixty-three patients with well-controlled type 2 diabetes (52 males, 11 females, age (Mean?±?SD): ?yrs, disease duration: ?yrs, HbA1c: %) were randomized to additional 45?mg of pioglitazone or placebo to their existing metformin and sulfonylurea” View full resource at hindawi.com
Most Recently Shared on July 27, 2011 at 1:42 am By:
Downregulation of the Proinflammatory State of Circulating Mononuclear Cells by Short-Term Treatment with Piogli... http://bit.ly/r1zFbl
Once-Daily Welchol (colesevelam HCl) for Oral Suspension Receives FDA Approval To be Mixed With Fruit Juice or Diet Soft Drinks
drugs.com — “Welchol (colesevelam) is used to treat patients with heterozygous familial hypercholesterolemia and to improve glycemic control in adults with type 2 diabetes mellitus. Includes Welchol side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 26, 2011 at 1:01 am By:
Drugs and Devices OW OW Health
Once-Daily Welchol (colesevelam HCl) for Oral Suspension Receives FDA Approval To be Mixed With Fruit Juic... http://bit.ly/nBCAIo #drug
GameFrontRSS: Team Ninja “Definitely Looking at” Making Use of Wii U Controller Functions: We know Ninja Gaiden 3 is headed t… http://bit.ly/qYEOjW | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “GameFrontRSS: Team Ninja “Definitely Looking at” Making Use of Wii U Controller Functions: We know Ninja Gaiden 3 is headed t… http://bit.ly/qYEOjW | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on July 5, 2011 at 8:46 pm By:
Autism link: Pregnant moms on anti-depressants: The risk was significantly elevated in women… http://goo.gl/fb/3Gtn7
Diabetes Minerva: Positioning Insulin vs GLP-1 Agonists in Type-2 Diabetes Insufficiently Controlled on Oral Agents GLP-1 Agonists go First; Tina Vilsbol; ADA 2011.
diabetes-editor.blogspot.com — “A clinicians view of: What's Hot in Diabetes” View full resource at diabetes-editor.blogspot.com
Most Recently Shared on June 27, 2011 at 10:23 pm By:
Hail the new kid in town - the case for using GLP-1 analogues in OHA failure in type-2 diabetes: http://t.co/09gTpP9
ADA: Early Liraglutide Tx Improves Diabetes Control (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “SAN DIEGO (MedPage Today) -- Early treatment with the glucagon-like peptide-1 agonist liraglutide (Victoza) appears to improve type 2 diabetic patients' overall glycemic control when compared with using the injected drug late in the course of the disease, researchers said here.” View full resource at qualitypointtech.net
Most Recently Shared on June 27, 2011 at 2:45 pm By:
ADA: Early Liraglutide Tx Improves Diabetes Control (CME/CE): SAN DIEGO (MedPage Today) -- Early treatment with th... http://bit.ly/mIyv7c
Tim Harlan, M.D.: Glycemic Index and Diabetes: The Jury's Still Out
huffingtonpost.com — “Glycemic index is certainly a useful tool, but it does not (yet) appear to be the single best answer for controlling blood sugars or preventing the development of Type 2 diabetes.” View full resource at huffingtonpost.com
Most Recently Shared on June 18, 2011 at 12:38 am By:
Tim Harlan, M.D.: Glycemic Index and Diabetes: The Jury's Still Out: Glycemic index is certainly a useful tool,... http://huff.to/kSHqi8
Tim Harlan, M.D.: Glycemic Index and Diabetes: The Jury's Still Out
huffingtonpost.com — “Glycemic index is certainly a useful tool, but it does not (yet) appear to be the single best answer for controlling blood sugars or preventing the development of Type 2 diabetes.” View full resource at huffingtonpost.com
Most Recently Shared on June 17, 2011 at 11:04 pm By:
Hisham Rana, MD Doctor and Physician
Commentary: "Glycemic Index and Diabetes: The Jury's Still Out" by Tim Harlan, M.D. http://huff.to/jLqxxB - #health
Advertisement
